Stocks · Health care · Surgical & Medical Instruments & Apparatus

Becton Dickinson

BDX Clue Score44
United States Fiscal year ends September CIK 0000010795 Results filed 5 Nov 2026

What the insiders did Net selling

By person

60 insiders · 211 transactions
15.6×

Thomas E. Polen holds 15.6 times base salary in stock. $21.83M of shares against $1.40M in salary for 2025.

Salary from the company's own proxy. The shares are what Thomas E. Polen last reported holding, valued at $198.13, the price Common Stock was last bought or sold at on the open market here, on 26 Oct 2026.

Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
Timothy M Ring
Director
—
$68.73M (8) scheduled
−$68.73M
59,391
0.0218%
$11.77M
−62.9%
Vincent A Forlenza
Chairman of the Board
—
$56.25M (14) scheduled
−$56.25M
194,048
0.0712%
$38.45M
+20.8%
James C Lim
Executive Vice President
—
$13.58M (9) scheduled
−$13.58M
24,742
0.0091%
$4.90M
+47.4%
Jeffrey S Sherman
Sr. VP and General Counsel
—
$11.01M (3) scheduled
−$11.01M
22,094
0.0081%
$4.38M
−6.9%
Alexandre Conroy
EVP of Integrated Supply Chain
—
$10.37M (7) scheduled
−$10.37M
21,260
0.0078%
$4.21M
−16.8%
Thomas E Polen Jr
Chairman, CEO and President
—
$10.24M (12) scheduled
−$10.24M
110,163
0.0404%
$21.83M
+951.1%
Samrat S. Khichi
EVP and General Counsel
—
$9.04M (4)
−$9.04M
9,251
0.0034%
$1.83M
−71.4%
Ribo Alberto Mas
EVP and Pres, Life Sciences
—
$7.94M (8) scheduled
−$7.94M
11,662
0.0043%
$2.31M
−26.1%
Gary M Cohen
Executive Vice President
—
$6.18M (2) scheduled
−$6.18M
71,770
0.0263%
$14.22M
−3.1%
Betty D Larson
EVP HR & CHRO
—
$5.14M (12) scheduled
−$5.14M
5,872
0.0022%
$1.16M
−44.6%
Roland Goette
EVP and President, EMEA
—
$3.78M (11) scheduled
−$3.78M
14,856
0.0055%
$2.94M
+241.0%
Nabil Shabshab
Executive Vice President
—
$3.55M (5) scheduled
−$3.55M
7,811
0.0029%
$1.55M
+16.6%
Simon D Campion
EVP and Segment President
—
$2.99M (6) scheduled
−$2.99M
10,319
0.0038%
$2.04M
−20.6%
Michael David Garrison
EVP & Pres Med.Essntl&BioPharm
—
$2.91M (13) scheduled
−$2.91M
13,172
0.0048%
$2.61M
+69.9%
Stephen Sichak
Executive Vice President
—
$2.80M (5) scheduled
−$2.80M
7,953
0.0029%
$1.58M
−8.0%
James W Borzi
EVP & Chief Supply Chain Offcr
—
$2.40M (7) scheduled
−$2.40M
2,775
0.0010%
$549.81K
+15.4%
Claire Fraser
Director
—
$1.93M (10)
−$1.93M
22,226
0.0082%
$4.40M
+0.9%
Ellen R Strahlman
Senior Vice President
—
$1.84M (1) scheduled
−$1.84M
6,898
0.0025%
$1.37M
+187.2%
Richard Byrd
EVP & President Interventional
—
$1.54M (5) scheduled
−$1.54M
13,849
0.0051%
$2.74M
+134.5%
John E Gallagher
VP, Corp Finance and Treasurer
—
$1.51M (4) scheduled
−$1.51M
1,975
0.0007%
$391.31K
−39.4%
David Hickey
EVP & President, Life Sciences
—
$1.20M (4) scheduled
−$1.20M
5,862
0.0022%
$1.16M
+63.9%
Patrick Kaltenbach
EVP & Pres Life Sciences
—
$1.05M (10)
−$1.05M
10,340
0.0038%
$2.05M
—
Gregory Hayes
Director
$1.01M (1)
—
+$1.01M
7,159
0.0026%
$1.42M
+47,627%
Linda M Tharby
Executive Vice President
—
$941.25K (1) scheduled
−$941.25K
13,437
0.0049%
$2.66M
+46.2%
Charles R Bodner
SVP Corp Fin Chief Acct Office
—
$905.09K (3) scheduled
−$905.09K
2,037
0.0007%
$403.59K
+2.0%
David Shan
EVP and Chief ISC Officer
—
$649.98K (3) scheduled
−$649.98K
8,926
0.0033%
$1.77M
+156.6%
Shana Carol Neal
EVP and Chief People Officer
—
$594.55K (3) scheduled
−$594.55K
23,966
0.0088%
$4.75M
+561.5%
Thomas J Spoerel
SVPController & Chief Acct Off
—
$581.88K (7)
−$581.88K
1,928
0.0007%
$381.99K
+63.8%
Rebecca W Rimel
Director
—
$424.85K (5)
−$424.85K
10,618
0.0039%
$2.10M
+39.0%
Bertram L Scott
Director
—
$371.94K (3)
−$371.94K
36,763
0.0135%
$7.28M
+25.1%
Jeffrey William Henderson
Director
$350.43K (1)
—
+$350.43K
9,143
0.0034%
$1.81M
+1,625%
Michael Feld
EVP, Chief Revenue Officer
—
$207.66K (15) scheduled
−$207.66K
19,568
0.0072%
$3.88M
+295.2%
David F Melcher
Director
$112.54K (1)
—
+$112.54K
6,180
0.0023%
$1.22M
+362.2%
Catherine M Burzik
Director
$82.57K (3)
$10.04K (1)
+$72.54K
14,264
0.0052%
$2.83M
+145.4%
John P Groetelaars
EVP
—
—
—
42,508
0.0156%
$8.42M
+16.9%
Bilal Muhsin
EVP & President Connected Care
—
—
—
41,359
0.0152%
$8.19M
+474.4%
Christopher R Reidy
CFO and EVP of Administration
—
—
—
31,524
0.0116%
$6.25M
+189.5%
Wilard J Overlock Jr
Director
—
—
—
28,942
0.0106%
$5.73M
−20.3%
Marshall O Larsen
Director
—
—
—
28,919
0.0106%
$5.73M
+27.9%
Gary A Mecklenburg
Director
—
—
—
25,453
0.0093%
$5.04M
+9.1%
Christopher Ian Montague Jones
Director
—
—
—
24,304
0.0089%
$4.82M
+61.3%
James F Orr
Director
—
—
—
24,257
0.0089%
$4.81M
+5.1%
Basil Anderson
Director
—
—
—
24,148
0.0089%
$4.78M
+5.1%
Christopher DelOrefice
EVP & Chief Financial Officer
—
—
—
22,982
0.0084%
$4.55M
—
Peter Menziuso
EVP and President, BDI
—
—
—
14,258
0.0052%
$2.82M
—
William A Tozzi
EVP Pres Interventional
—
—
—
12,830
0.0047%
$2.54M
+45.4%
Antoine C Ezell
EVP, President Americas & CMO
—
—
—
11,970
0.0044%
$2.37M
+132.8%
R Andrew Eckert
Director
—
—
—
10,423
0.0038%
$2.07M
+777.4%
Claire Pomeroy
Director
—
—
—
9,982
0.0037%
$1.98M
+120.7%
Rishi Grover
EVP and Chief ISC Officer
—
—
—
9,439
0.0035%
$1.87M
+9,434%
Vitor Roque
EVP & Chief Financial Officer
—
—
—
8,041
0.0030%
$1.59M
+44.1%
Lanesha Minnix
EVP and General Counsel
—
—
—
7,492
0.0028%
$1.48M
—
Michelle Quinn
EVP and General Counsel
—
—
—
6,927
0.0025%
$1.37M
+105.0%
Pavan Kumar Mocherla
EVP & President, Greater Asia
—
—
—
5,763
0.0021%
$1.14M
+712.8%
Carrie L Byington
Director
—
—
—
5,018
0.0018%
$994.22K
+2,397%
William M Brown
Director
—
—
—
4,663
0.0017%
$923.88K
+2,595%
Joanne Waldstreicher
Director
—
—
—
3,391
0.0012%
$671.86K
+7,607%
Pamela L. Spikner
SVP Controller & CAO
—
—
—
3,323
0.0012%
$658.39K
+167.6%
Robert Luther Huffines
Director
—
—
—
1,279
0.0005%
$253.41K
+127,800%
Jacqueline Wright
Director
—
—
—
1,279
0.0005%
$253.41K
+127,800%